SciSparc (SPRC) Non-cash Items (2017 - 2018)
SciSparc (SPRC) posted Non-cash Items of -$340000.0 for Q2 2018, up 39.5% sequentially from -$562000.0 in Q2 2017, and up 39.5% YoY from -$243724.5 in Q2 2017.
SciSparc (SPRC) Non-cash Items (2017 - 2018) Analysis & Trends
SciSparc has reported Non-cash Items for 2 years, with the latest figure at -$340000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -340,000.00 |
| Jun 30, 2018 | -340,000.00 |
| Jun 30, 2017 | -562,000.00 |
| Jun 30, 2017 | -562,000.00 |